somatic mutations affect key pathways lung adenocarcinoma 
determining genetic basis cancer requires comprehensive analyses large collections histopathologically well classified primary tumours report results collaborative study discover somatic mutations human lung adenocarcinomas dna sequencing genes known potential relationships cancer revealed somatic mutations across samples analysis identified genes mutated significantly high frequencies thus probably involved carcinogenesis frequently mutated genes include tyrosine kinases among egfr homologue erbb4 multiple ephrin receptor genes notably epha3 vascular endothelial growth factor receptor kdr ntrk genes data provide evidence somatic mutations primary lung adenocarcinoma several tumour suppressor genes involved cancers including nf1 apc rb1 atm sequence changes ptprd well frequently deleted gene lrp1b observed mutational profiles correlate clinical features smoking status dna repair defects results reinforced data integration including single nucleotide polymorphism array gene expression array findings shed light several important signalling pathways involved lung adenocarcinoma suggest new molecular targets treatment 
